Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 11
2004 17
2005 20
2006 17
2007 14
2008 17
2009 26
2010 26
2011 36
2012 42
2013 34
2014 30
2015 36
2016 31
2017 65
2018 57
2019 51
2020 78
2021 103
2022 93
2023 89
2024 68

Text availability

Article attribute

Article type

Publication date

Search Results

868 results

Results by year

Filters applied: . Clear all
Page 1
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
Horn L, Wang Z, Wu G, Poddubskaya E, Mok T, Reck M, Wakelee H, Chiappori AA, Lee DH, Breder V, Orlov S, Cicin I, Cheng Y, Liu Y, Fan Y, Whisenant JG, Zhou Y, Oertel V, Harrow K, Liang C, Mao L, Selvaggi G, Wu YL. Horn L, et al. Among authors: mao l. JAMA Oncol. 2021 Nov 1;7(11):1617-1625. doi: 10.1001/jamaoncol.2021.3523. JAMA Oncol. 2021. PMID: 34473194 Free PMC article. Clinical Trial.
Genetically proxied antidiabetic drugs targets and stroke risk.
Zhu Y, Li M, Wang H, Yang F, Pang X, Du R, Zhang J, Huang X. Zhu Y, et al. Among authors: li m. J Transl Med. 2023 Sep 30;21(1):681. doi: 10.1186/s12967-023-04565-x. J Transl Med. 2023. PMID: 37777789 Free PMC article.
Solid-Phase Electrosynthesis.
Li M, Li Y. Li M, et al. Acc Chem Res. 2023 Dec 19;56(24):3694-3703. doi: 10.1021/acs.accounts.3c00620. Epub 2023 Dec 6. Acc Chem Res. 2023. PMID: 38053314
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial.
He J, Su C, Liang W, Xu S, Wu L, Fu X, Zhang X, Ge D, Chen Q, Mao W, Xu L, Chen C, Hu B, Shao G, Hu J, Zhao J, Liu X, Liu Z, Wang Z, Xiao Z, Gong T, Lin W, Li X, Ye F, Liu Y, Ma H, Huang Y, Zhou J, Wang Z, Fu J, Ding L, Mao L, Zhou C. He J, et al. Among authors: mao l. Lancet Respir Med. 2021 Sep;9(9):1021-1029. doi: 10.1016/S2213-2600(21)00134-X. Epub 2021 Jul 21. Lancet Respir Med. 2021. PMID: 34280355 Clinical Trial.
Coarse-grained tight-binding models.
Liu TX, Mao L, Pistol ME, Pryor C. Liu TX, et al. Among authors: mao l. J Phys Condens Matter. 2022 Jan 5;34(12). doi: 10.1088/1361-648X/ac443f. J Phys Condens Matter. 2022. PMID: 34920442
868 results